Nxera Pharma Co (Nxera Pharma Co) Total Inventories : $20.16 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Total Inventories?

Nxera Pharma Co's total inventories for the quarter that ended in Dec. 2023 was $20.16 Mil. Nxera Pharma Co's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $23.60 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nxera Pharma Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-2.78.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nxera Pharma Co's Days Inventory for the three months ended in Dec. 2023 was 177.15.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nxera Pharma Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.52.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nxera Pharma Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.47.

Nxera Pharma Co Total Inventories Historical Data

The historical data trend for Nxera Pharma Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Total Inventories Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

0.24

20.16

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															0.24	-	-	27.03	20.16

Nxera Pharma Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Nxera Pharma Co (OTCPK:SOLTF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Nxera Pharma Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(342.968	+	0.75 * 35.171	+	0.5 * 20.162	-	627.775
-	0	-	0)	/	89.4464
=	-2.78

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nxera Pharma Co's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	23.595	/	12.154	*	365 / 4
	=	177.15

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nxera Pharma Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	12.154	/	23.595
	=	0.52

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nxera Pharma Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	23.595	/	50.645
	=	0.47

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Nxera Pharma Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.